| ¿µ¹® | thought | ÇÑ±Û | »ç°í |
|---|---|---|---|
| ¼³¸í | 1. »ý°¢ÇÏ°í ±Ã¸®ÇÔ. 2. ½É»óÀ̳ª Áö½ÄÀ» »ç¿ëÇÏ´Â ¸¶À½ÀÇ ÀÛ¿ë. ÀÌ¿¡ ÀÇÇÏ¿© ¹®Á¦¸¦ ÇØ°áÇÑ´Ù. Á÷°üÀû »ç°í, ºÐ¼®Àû »ç°í, ÁýÁßÀû »ç°í, È®»êÀû »ç°í µîÀÌ ÀÖ´Ù. |
||
| COT | colony overlay test; content of thought; contralateral optic tectum; critical off-time |
|---|---|
| Nutcracker syndrome | the vein from the left kidney is obstructed by one of the major arteries leaving the aorta. It can c... |
| CAS | calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car... |
| CES-D | Center for Epidemiological Studies of Depression [scale] |
| CHAS | Center for Health Administration Studies |
| FSU | Former Soviet Union |
|---|---|
| TDI | Thought Disorder Index |
| CES-D | Center for Epidemiologic Studies - Depression |
| CES-D | Center for Epidemiologic Studies - Depression Scale |
| CES-D | Center for Epidemiological Studies Depression |
| omnipotence of thought | A childish or magical thought process whereby instantaneous gratification of fantasies and wishes is believed to be imminent. (05 Mar 2000) |
|---|---|
| thought broadcasting | The delusion of experiencing one's thoughts, as they occur, as being broadcast from one's head to the external world where other people can hear them. (05 Mar 2000) |
| thought insertion | The delusion that one's thoughts are not really one's own but are being placed into one's mind by an external force. (05 Mar 2000) |
| thought process disorder | An intellectual function symptom of schizophrenia, manifested by irrelevance and incoherence of verbal productions ranging from simple blocking and mild circumstantiality to total loosening of associations. (05 Mar 2000) |
| thought withdrawal | The delusion that one's thoughts have been removed from one's head resulting in a diminished number of thoughts remaining. (05 Mar 2000) |
| trend of thought | Thinking with a tendency toward or centreing on a particular idea with a particular affect. (05 Mar 2000) |
| extrasensory thought transference | The knowledge or communication by one person with the mental processes of another through channels other than known physical or perceptual processes. (12 Dec 1998) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|